Mosaic 13q13.2-ter deletion restricted to tissues of ectodermal and mesodermal origins.
The '13q-' syndrome shows widely variable manifestations. Investigation of the involvement of different tissues has never been reported in patients with 13q- syndrome previously. We describe a patient with mosaicism for del(13q) and clinical features of 13q- syndrome. The mother of the patient was professionally exposed to aniline colorants and glue components during the whole pregnancy. The patient had dysmorphic features, skeletal anomalies and brain malformations with agenesis of the corpus callosum, vermian hypoplasia and IVth ventricular system abnormalities. Eye examination revealed chorioretinal coloboma and irregular dispersion of retinal pigment in the right eye. The karyotype analyses and the molecular studies performed on peripheral lymphocytes, oral swab and cells of urinary tract were normal whereas a deletion of the long arm of chromosome 13 (13q13.2) was found in skin fibroblasts and in hair cells. We hypothesized that the 13q deletion arose during the third week after conception possibly due to a teratogenic effect and that tissue of mesodermal and ectodermal origin are involved. We suggest analysing a fibroblast karyotype when a diagnosis of 13q- syndrome is suspected on clinical ground. The role of teratogens in causing this type of mosaic chromosome abnormality also warrants further investigation.
Melis
Daniela
D
Department of Pediatrics, Federico II University, Naples, Italy Dulbecco Telethon Institute, Rome.
Pia Sperandeo
Maria
M
Perone
Lucia
L
Staiano
Annamaria
A
Andria
Generoso
G
Sebastio
Gianfranco
G
D000015:Abnormalities, Multiple / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D000814:Aniline Compounds / Q000009:adverse effects; D002273:Carcinogens; D002872:Chromosome Deletion; D002882:Chromosomes, Human, Pair 13 / Q000235:genetics*; D003103:Coloboma / Q000139:chemically induced / Q000235:genetics / Q000473:pathology; D005260:Female; D005317:Fetal Growth Retardation / Q000139:chemically induced / Q000235:genetics / Q000473:pathology; D005347:Fibroblasts / Q000473:pathology; D005500:Follow-Up Studies; D006197:Hair / Q000473:pathology; D006801:Humans; D007223:Infant; D018811:Maternal Exposure / Q000009:adverse effects; D009030:Mosaicism / Q000139:chemically induced; D016273:Occupational Exposure / Q000009:adverse effects; D012867:Skin / Q000473:pathology
D000814:Aniline Compounds; D002273:Carcinogens; C023650:aniline